Optimizing platelet P2Y12 inhibition for patients undergoing PCI
about
Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood.Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel.A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes.Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
P2860
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@ast
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@en
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@nl
type
label
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@ast
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@en
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@nl
prefLabel
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@ast
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@en
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@nl
P2860
P1476
Optimizing platelet P2Y12 inhibition for patients undergoing PCI
@en
P2093
Steven Steinhubl
P2860
P304
P356
10.1111/J.1527-3466.2007.00013.X
P407
P577
2007-01-01T00:00:00Z